Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16933746 | 0.97 | — | — | |
| SCHEMBL5906000 | 0.78 | CYP1A2 (0.37) | CYP1A2CTSKSHBG | |
| SCHEMBL4682936 | 0.78 | CHRM5 (0.32) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL16933895 | 0.76 | ALDH1A1 (0.32) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL28930071 | 0.76 | SHBG (0.42) | CYP1A2CTSKSHBG | |
| SCHEMBL16933957 | 0.72 | — | — | |
| SCHEMBL8020386 | 0.72 | CTSK (0.40) | CYP1A2CTSK | |
| SCHEMBL9819745 | 0.72 | CTSK (0.40) | CYP1A2CTSK | |
| SCHEMBL16933893 | 0.72 | METAP1 (0.45) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL3178350 | 0.72 | METAP1 (0.36) | CTSKMETAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| CN-109843963-B | Isocyanate composition, method for producing isocyanate polymer, and isocyanate polymer | 旭化成株式会社 | 2022-05-13 | — | — | CN | disclosed |
| EP-3536683-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-11-24 | — | — | EP | disclosed |
| US-11174337-B2 | Isocyanate composition, method for producing isocyanate polymer and isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-11-16 | — | — | US | disclosed |
| CN-107963982-B | Polyisocyanate composition and isocyanate polymer composition | 旭化成株式会社 | 2021-11-12 | — | — | CN | disclosed |
| EP-3372579-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2020-10-28 | — | — | EP | disclosed |
| EP-2915803-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2020-07-22 | — | — | EP | disclosed |
| US-6905637-B2 | Electrically conductive thermoset composition, method for the preparation thereof, and articles derived therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-06-14 | — | — | US | disclosed |
| US-20050109990-A1 | Electrically conductive thermoset composition, method for the preparation thereof, and articles derived therefrom | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2005-05-26 | — | — | US | disclosed |
| US-6812276-B2 | CURABLE MIXTURE OF A FUNCTIONALIZED POLY(ARYLENE ETHER) SUCH AS METHACRYLATE-ENDCAPPED POLY(2,6-DIMETHYLPHENYL ETHER), AN ALKENYL AROMATIC MONOMER, AND AN ALKOXYLATED ACRYLOYL MONOMER; GOOD STIFFNESS, TOUGHNESS, AND HEAT RESISTANCE | GENERAL ELECTRIC COMPANY | 2004-11-02 | — | — | US | disclosed |
| EP-1378534-A1 | Poly(arylene ether)-containing thermoset composition | GENERAL ELECTRIC COMPANY (US) | 2004-01-07 | — | — | EP | disclosed |
| EP-1370611-A1 | ELECTRICALLY CONDUCTIVE THERMOSET COMPOSITION, METHOD FOR THE PREPARATION THEREOF, AND ARTICLES DERIVED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2003-12-17 | — | — | EP | disclosed |
| US-6627704-B2 | Blend of polyphenylene ether, styrene compound and acrylic ester | GENERAL ELECTRIC COMPANY | 2003-09-30 | — | — | US | disclosed |
| US-20030096123-A1 | Curable mixture of a functionalized poly(arylene ether) such as methacrylate-endcapped poly(2,6-dimethylphenyl ether), an alkenyl aromatic monomer, and an alkoxylated acryloyl monomer; good stiffness, toughness, and heat resistance | GENERAL ELECTRIC COMPANY | 2003-05-22 | — | — | US | disclosed |
| US-20020177027-A1 | Electrically conductive thermoset composition, method for the preparation thereof, and articles derived therefrom | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2002-11-28 | — | — | US | disclosed |
| WO-2002057365-A1 | ELECTRICALLY CONDUCTIVE THERMOSET COMPOSITION, METHOD FOR THE PREPARATION THEREOF, AND ARTICLES DERIVED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2002-07-25 | — | — | WO | disclosed |
| US-20010053820-A1 | Poly(arylene ether)-containing thermoset composition, method for the preparation thereof, and articles derived therefrom | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2001-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | CHRM5 3418/4885CYP1A2 195/4885ADRA2C 4639/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | CHRM5 3513/4885CYP1A2 183/4885ADRA2C 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.